Witnessing the stock’s movement on the chart, on Thursday, Cytek BioSciences Inc (NASDAQ: CTKB) had a quiet start as it plunged -4.99% to $4.57, before settling in for the price of $4.81 at the close. Taking a more long-term approach, CTKB posted a 52-week range of $2.37-$7.30.
It was noted that the giant of the Healthcare sector posted annual sales growth of 18.28% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 18.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -182.29%. This publicly-traded company’s shares outstanding now amounts to $127.86 million, simultaneously with a float of $116.00 million. The organization now has a market capitalization sitting at $584.34 million. At the time of writing, stock’s 50-day Moving Average stood at $3.99, while the 200-day Moving Average is $3.88.
Cytek BioSciences Inc (CTKB) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Cytek BioSciences Inc’s current insider ownership accounts for 9.17%, in contrast to 58.14% institutional ownership. According to the most recent insider trade that took place on Jun 02 ’25, this organization’s Chief Financial Officer bought 35,000 shares at the rate of 2.78, making the entire transaction reach 97,300 in total value, affecting insider ownership by 55,746.
Cytek BioSciences Inc (CTKB) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year. Cytek BioSciences Inc’s EPS decrease for this current 12-month fiscal period is -182.29% and is forecasted to reach -0.14 in the upcoming year.
Cytek BioSciences Inc (NASDAQ: CTKB) Trading Performance Indicators
Let’s observe the current performance indicators for Cytek BioSciences Inc (CTKB). It’s Quick Ratio in the last reported quarter now stands at 4.48. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.97.
In the same vein, CTKB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.10, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be -0.14 at the market close of one year from today.
Technical Analysis of Cytek BioSciences Inc (CTKB)
Going through the that latest performance of [Cytek BioSciences Inc, CTKB]. Its last 5-days volume of 1.38 million indicated improvement to the volume of 0.98 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 80.34% While, its Average True Range was 61.36.
Raw Stochastic average of Cytek BioSciences Inc (CTKB) in the period of the previous 100 days is set at 79.14%, which indicates a major rise in contrast to 68.92% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.26 that was higher than 0.21 volatility it exhibited in the past 100-days period.
